Safety Needles

Safety Needles

Global Safety Needles Market to Reach US$4.3 Billion by 2030

The global market for Safety Needles estimated at US$2.7 Billion in the year 2023, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Active Safety Needles, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Passive Safety Needles segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.2 Million While China is Forecast to Grow at 10.2% CAGR

The Safety Needles market in the U.S. is estimated at US$704.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Safety Needles Market - Key Trends & Drivers Summarized

Safety needles are medical devices designed to protect healthcare workers and patients from needlestick injuries and the associated risks of bloodborne pathogen transmission. These needles are equipped with safety features such as retractable or shielded needles that activate immediately after use, preventing accidental sticks. The adoption of safety needles has become a critical component in healthcare settings, driven by stringent regulations and the need to enhance workplace safety. These devices are used in various medical procedures, including injections, blood draws, and IV catheter placements. By minimizing the risk of needlestick injuries, safety needles help reduce the incidence of infections from pathogens such as HIV, hepatitis B, and hepatitis C, which can have serious implications for healthcare workers and patients alike.

Technological advancements have significantly improved the design and functionality of safety needles. Modern safety needles incorporate features such as automatic retraction, passive shielding, and easy one-handed operation, enhancing usability and safety. Advances in materials science have led to the development of needles that are not only safer but also more comfortable for patients, with ultra-thin walls and lubricated coatings that reduce pain and tissue damage. Additionally, the integration of safety mechanisms that do not interfere with the needle`s performance or increase the complexity of use has been a key focus, ensuring that healthcare workers can adopt these devices without additional training burdens. The increased emphasis on ergonomic designs has also improved user comfort and reduced the risk of repetitive strain injuries among healthcare providers.

The growth in the safety needles market is driven by several factors, including stringent regulatory requirements, increasing awareness of occupational hazards, and the rising incidence of chronic diseases requiring frequent injections. Regulatory bodies worldwide have mandated the use of safety needles in healthcare settings to protect workers from needlestick injuries, driving widespread adoption. The heightened awareness of occupational health and safety has also spurred demand for these devices, as healthcare institutions strive to provide safer working environments. The rising prevalence of chronic conditions such as diabetes, which necessitates regular insulin injections, and the increased use of injectable biologics for various medical conditions, have further boosted the demand for safety needles. Technological advancements that enhance the safety and usability of these devices, coupled with growing investments in healthcare infrastructure, are also contributing to market growth.

 

Select Competitors (Total 101 Featured) -

• Advin Health Care
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Argon Medical Devices, Inc.
• A. Menarini Diagnostics Srl
• Allison Medical, Inc.
• Axel Bio Corporation, Inc.
• Cambridge Sensors Ltd.
• Bionic Medizintechnik GmbH
• AdvaCare Pharma
• Berpu Medical Technology Co., Ltd.
• ANHUI KANGDA MEDICAL PRODUCTS CO., LTD.
• AYSET TIBBI URUNLER SAN. A.S.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.